Related references
Note: Only part of the references are listed.EIDOS A Mechanistic Classification of Adverse Drug Effects
Robin E. Ferner et al.
DRUG SAFETY (2010)
Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer
Chris R. Cardwell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort
Jane Green et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Oral bisphosphonates and oesophageal cancer
Diane K. Wysowski
BMJ-BRITISH MEDICAL JOURNAL (2010)
A Strategy for Regulatory Action When New Adverse Effects of a Licensed Product Emerge
Jeffrey K. Aronson et al.
DRUG SAFETY (2009)
The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?
Jeremy Howick et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2009)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
Joining the DoTS: new approach to classifying adverse drug reactions
JK Aronson et al.
BRITISH MEDICAL JOURNAL (2003)
A model for the future conduct of pharmacovigilance
PC Waller et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2003)
Share Paper
